<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410582/" ref="ordinalpos=1954&amp;ncbi_uid=4152063&amp;link_uid=PMC3410582" image-link="/pmc/articles/PMC3410582/figure/fig01/" class="imagepopup">Figure 1.  From: Androgen receptor as a targeted therapy for breast cancer. </a></div><br /><div class="p4l_captionBody">Schematic of signaling crosstalk between androgen receptor and epidermal growth factor receptor pathways. Concurrent signaling via androgen receptor with the epidermal growth factor receptor (left) leads to cell cycle arrest. Signaling via one or the other pathway (right) leads to growth proliferation. p21 is required for AR signaling in either situation.</div></div>